Is a testosterone level of 1600 ng/dL actually dangerous on TRT?

What did @socalurologyinstitute actually say?

The creator's core argument is that a testosterone reading of 1600 ng/dL isn't automatically a problem. The key variable, he says, is timing: "when did you do an injection relative to the blood tests?" If the draw happened one or two days post-injection, you've caught peak levels, and that number is misleading. If it happened five or six days out, he says 1600 is genuinely too high. His practical advice: pull labs several days after an injection to get a meaningful trough-adjacent reading rather than a peak.

He's also pushing back on what he frames as reflexive clinical panic — doctors who see a high number and immediately say cut the dose without asking when the blood was drawn. That's a real problem in TRT management, and naming it is worth something.

Does the science back this up?

Yes, mostly. The pharmacokinetics of testosterone cypionate are well-documented, and peak versus trough timing matters enormously for interpreting labs. This isn't controversial among endocrinologists who actually manage TRT patients regularly.

Testosterone cypionate has a half-life of roughly 8 days. After a single intramuscular injection, serum testosterone peaks somewhere between 24 and 72 hours, then declines gradually. Bhasin et al. (2018, Journal of Clinical Endocrinology and Metabolism) documented this pattern in clinical pharmacokinetic studies, showing that peak-to-trough variation can exceed 60-70% over a weekly injection cycle. Drawing labs at peak versus trough on the same dose can produce readings that look like two completely different patients. A 1600 ng/dL reading 36 hours post-injection and a 600 ng/dL reading six days out are both plausible from the same weekly dose. The creator is correct that context is everything here.

The Endocrine Society's clinical practice guideline (Bhasin et al., 2018) recommends drawing testosterone levels midway between injections for patients on weekly cypionate — not at peak, not at trough. That's a slightly different recommendation than the creator's "five or six days" suggestion, though the principle is the same: don't draw at peak.

What did they get wrong (or right)?

He got the main point right. The timing issue is real and clinically important. But there are two things he glossed over that matter.

First, he frames 1600 ng/dL as acceptable if it's a peak reading, without discussing what that peak actually means for the patient's exposure over the full injection cycle. Total testosterone exposure, measured as area under the curve, is what drives both benefits and risks, not just the peak number in isolation. A patient running peaks of 1600 will still have higher average testosterone exposure than someone peaking at 900, even if both are on "the same dose." Cavender and Bhatt (2019, Urology) noted that supraphysiologic peaks may contribute to erythrocytosis and cardiovascular strain independent of trough values.

Second, he doesn't mention free testosterone or hematocrit. Total testosterone at 1600 is one data point. Free testosterone, estradiol, and hematocrit are the numbers that actually tell you whether someone is experiencing harm. Skipping that context leaves patients thinking total T is the only thing worth monitoring, which it isn't.

Credit where it's due: his pushback against reflexive dose reduction without context is clinically sound and probably prevents unnecessary under-treatment.

What should you actually know?

If you're on testosterone cypionate and your labs come back high, the first question is always: when was your last injection? This isn't a loophole to justify supraphysiologic levels — it's basic pharmacokinetics that every prescriber should apply before adjusting a dose.

The Endocrine Society recommends that total testosterone levels for men on TRT stay within the normal physiologic range for young healthy males, roughly 400-700 ng/dL at trough or midpoint. Consistently supraphysiologic levels, even at trough, warrant dose adjustment regardless of how you feel. Risks at chronically elevated levels include erythrocytosis, elevated hematocrit, and potential cardiovascular effects, as reviewed by Shores et al. (2020, JAMA Internal Medicine).

Timing your labs matters, but so does what you do with the results. A well-run TRT protocol means drawing labs at a consistent time in your injection cycle, tracking free testosterone and estradiol alongside total T, and monitoring hematocrit. A single total testosterone number without that context is incomplete information, whether it's 600 or 1600.